Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Lawsuits/Bankruptcy
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Commercial
Lawsuits/Bankruptcy
Lawsuits/Bankruptcy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lawsuits/Bankruptcy
Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell...
Biospace News
-
February 26, 2021
Lawsuits/Bankruptcy
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Toronto Stock Exchange:CRON
Lawsuits/Bankruptcy
Biophytis Reports 2020 Full Year Results
Lawsuits/Bankruptcy
Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million Nasdaq:COLL
Lawsuits/Bankruptcy
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Lawsuits/Bankruptcy
Aquestive Therapeutics Provides Business Update Nasdaq:AQST
Globenewswire News
-
January 7, 2021
0
Lawsuits/Bankruptcy
Canopy Growth Files Patent Infringement Lawsuit Against GW Pharmaceuticals – FirstWord...
Firstwordpharma News
-
December 25, 2020
0
Lawsuits/Bankruptcy
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility Nasdaq:TNXP
Globenewswire News
-
December 23, 2020
0
Lawsuits/Bankruptcy
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for...
Globenewswire News
-
December 22, 2020
0
Lawsuits/Bankruptcy
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 for...
Biospace News
-
December 22, 2020
0
1
2
3
...
21
Page 1 of 21
- Advertisement -
MOST POPULAR
Tonix Pharmaceuticals Joins the Alliance for Biosecurity
October 15, 2019
Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with...
April 24, 2019
Inflammatory Bowel Disease Insight Report: Current Therapies, Drug Pipeline and Outlook
November 19, 2019
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near...
February 19, 2019
Load more
HOT NEWS
Deals
PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration...
Commercial
Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Third...
Immuno-oncology
AstraZeneca, Daiichi Sankyo’s trastuzumab deruxtecan achieves response rate of 60.9% in...
Commercial
OBI Pharma Announces Poster Presentations at AACR 2019 for Novel Globo...
